265 filings
Page 8 of 14
8-K
v1jpusk3iu8owvz4w9i
7 May 14
Other Events
12:00am
8-K
iqy xwgysmieatbsf7n
2 May 14
Immunomedics Prices $30 Million Public Offering of Common Stock
12:00am
8-K
bjd96jk
7 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
fi4bq0liswdg47169 bm
10 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
dkb5la0dx61d7q1wq
4 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
o4i 1d0zsi43n
4 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
b7s ovrzb6speu
9 Oct 13
Immunomedics Announces Termination of Agreement and Return of Worldwide Rights to Veltuzumab for All Non-cancer Indications
12:00am
8-K
r1jbl5w8 myww1d3v
4 Oct 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
74owbe5
5 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
xhnipr
22 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
fgio0296vtwwhys 2zl
22 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
i64dcob0mcoh
20 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
9cs1r0xuu0v9p2x
8 May 13
Results of Operations and Financial Condition
12:00am
8-K
7j8rhf lexn8
1 Apr 13
Other Events
12:00am
8-K
04tf14lw
27 Feb 13
Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters
12:00am
8-K
erghtubg703vwhzur7dc
22 Feb 13
Immunomedics Prices $14.0 Million Public Offering of
12:00am
8-K
bhbbrconf4p5
7 Feb 13
Results of Operations and Financial Condition
12:00am
8-K
nrqni qigq
6 Dec 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yclb1wqeym 41fbnvq
8 Nov 12
Results of Operations and Financial Condition
12:00am
8-K
7qtpw0
30 Aug 12
Departure of Directors or Certain Officers
12:00am